NASDAQ:WBA - Walgreens Boots Alliance Stock Price, Forecast & News

Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."

Walgreens Boots Alliance announced a quarterly dividend on Wednesday, October 23rd. Shareholders of record on Monday, November 18th will be paid a dividend of $0.458 per share on Thursday, December 12th. This represents a $1.83 annualized dividend and a yield of 3.10%. The ex-dividend date is Friday, November 15th. View Walgreens Boots Alliance's Dividend History.

Walgreens Boots Alliance Inc (NASDAQ:WBA) announced its quarterly earnings results on Monday, October, 28th. The pharmacy operator reported $1.43 earnings per share for the quarter, beating analysts' consensus estimates of $1.41 by $0.02. The pharmacy operator earned $33.95 billion during the quarter, compared to the consensus estimate of $33.88 billion. Walgreens Boots Alliance had a return on equity of 21.99% and a net margin of 2.91%. The company's revenue for the quarter was up 1.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.48 earnings per share. View Walgreens Boots Alliance's Earnings History.

Walgreens Boots Alliance is scheduled to release their next quarterly earnings announcement on Thursday, December 19th 2019. View Earnings Estimates for Walgreens Boots Alliance.

Walgreens Boots Alliance issued an update on its FY 2020 Pre-Market earnings guidance on Monday, October, 28th. The company provided earnings per share guidance of $$5.81-6.17 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $$5.96.

19 Wall Street analysts have issued 1 year price targets for Walgreens Boots Alliance's shares. Their forecasts range from $49.00 to $94.00. On average, they expect Walgreens Boots Alliance's share price to reach $61.88 in the next twelve months. This suggests a possible upside of 4.7% from the stock's current price. View Analyst Price Targets for Walgreens Boots Alliance.

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last year. There are currently 4 sell ratings, 13 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Walgreens Boots Alliance.

Press coverage about WBA stock has been trending somewhat negative this week, according to InfoTrie. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Walgreens Boots Alliance earned a media sentiment score of -1.6 on InfoTrie's scale. They also gave media stories about the pharmacy operator a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an effect on the company's share price in the near term. View News Stories for Walgreens Boots Alliance.

Some companies that are related to Walgreens Boots Alliance include CVS Health (CVS), Covetrus (CVET), Rite Aid (RAD), Petmed Express (PETS), Diplomat Pharmacy (DPLO), 111 (YI), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other Walgreens Boots Alliance investors own include Verizon Communications (VZ), HCA Healthcare (HCA), AT&T (T), General Electric (GE), Pandora Media (P), Ryder System (R), Bank of America (BAC), NVIDIA (NVDA), Alibaba Group (BABA) and Wells Fargo & Co (WFC).

Walgreens Boots Alliance's stock is owned by many different of institutional and retail investors. Top institutional shareholders include State Street Corp (5.23%), Sumitomo Mitsui Trust Holdings Inc. (0.38%), Parametric Portfolio Associates LLC (0.35%), Markel Corp (0.24%), California Public Employees Retirement System (0.22%) and Schafer Cullen Capital Management Inc (0.21%). Company insiders that own Walgreens Boots Alliance stock include Kathleen Wilson-Thompson, Kimberly R Scardino, Marco Patrick Anthony Pagni, Nancy M Schlichting, Ornella Barra, Stefano Pessina and William C Foote. View Institutional Ownership Trends for Walgreens Boots Alliance.

WBA stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Teacher Retirement System of Texas, Envestnet Asset Management Inc., Manitou Investment Management Ltd., Boston Private Wealth LLC, Russell Investments Group Ltd., River Road Asset Management LLC and Prentiss Smith & Co. Inc.. View Insider Buying and Selling for Walgreens Boots Alliance.

WBA stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Cullen Capital Management LLC, Pictet Asset Management Ltd., Donaldson Capital Management LLC, Railway Pension Investments Ltd, First Trust Advisors LP, California Public Employees Retirement System and State Street Corp. Company insiders that have bought Walgreens Boots Alliance stock in the last two years include Ornella Barra and Stefano Pessina. View Insider Buying and Selling for Walgreens Boots Alliance.

Shares of WBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of WBA stock can currently be purchased for approximately $59.10.

Walgreens Boots Alliance has a market capitalization of $52.75 billion and generates $136.87 billion in revenue each year. The pharmacy operator earns $3.98 billion in net income (profit) each year or $5.99 on an earnings per share basis. Walgreens Boots Alliance employs 342,000 workers across the globe.View Additional Information About Walgreens Boots Alliance.

The official website for Walgreens Boots Alliance is http://www.walgreensbootsalliance.com/.

Walgreens Boots Alliance's mailing address is 108 Wilmot Road, Deerfield IL, 60015. The pharmacy operator can be reached via phone at 847-315-2500 or via email at [email protected]